Takeda Pharm is a Health Care industry firm, which concentrates their activity in the Pharmaceuticals and Biotechnology sector. Takeda Pharm headquarters are in Japan, where the firm is listed.

At the time of this analysis, Takeda Pharm stocks were trading at a price of
3,883.00
JPY after
hiking a 17.40% last month.

According to the chart, Takeda Pharm has Price to Earnings ratio of 19.00, which is higher than the amount show in companies from Japan. However, it is lower than the average of Pharmaceuticals and Biotechnology sector. The company should be deeply studied because P/E ought to be quite similar among firms from the same sector unless they carry a very different strategy. Thus, Takeda Pharm financial report should be analyzed to confirm the company is undervalued.